Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 21,591 | 9,323 | 3,527 | 1,401 | 2 |
| Depreciation Amortization | 11,519 | 8,630 | 5,754 | 2,878 | 9,840 |
| Accounts receivable | -8,368 | 10,862 | 8,546 | 9,186 | -7,824 |
| Accounts payable and accrued liabilities | 449 | -1,379 | 1,355 | 2,149 | -4,734 |
| Other Working Capital | -17,854 | -10,353 | -9,126 | -4,474 | -44,496 |
| Other Operating Activity | 19,672 | -529 | -4,117 | -8,497 | 31,385 |
| Operating Cash Flow | $27,009 | $16,554 | $5,939 | $2,643 | $-15,827 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -140 | -95 | -68 | N/A | N/A |
| Purchase Of Investment | -23,813 | -12,511 | -10,543 | -4,950 | -4,836 |
| Sale Of Investment | 17,328 | 14,151 | 978 | N/A | 18,940 |
| Purchase Sale Intangibles | -12,500 | -12,500 | -12,500 | -12,500 | -7,000 |
| Other Investing Activity | -12,500 | -12,500 | -12,500 | -12,500 | -7,000 |
| Investing Cash Flow | $-19,125 | $-10,955 | $-22,133 | $-17,450 | $7,104 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 12,500 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -277 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $12,223 |
| Beginning Cash Position | 78,792 | 78,792 | 78,792 | 78,792 | 75,292 |
| End Cash Position | 86,676 | 84,391 | 62,598 | 63,985 | 78,792 |
| Net Cash Flow | $7,884 | $5,599 | $-16,194 | $-14,807 | $3,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 27,009 | 16,554 | 5,939 | 2,643 | -15,827 |
| Capital Expenditure | -140 | -95 | -68 | N/A | N/A |
| Free Cash Flow | 26,869 | 16,459 | 5,871 | 2,643 | -15,827 |